Clinical Trials · NCT02437032

Gonadotropin Type in Ovarian Stimulation

CompletedPhase 4Gonadorelin (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
IVI Madrid
Enrollment
100
Start date
Apr 2009
Locations
See registry
Primary endpoint
GDF-9 and BMP-15 secretion
View Gonadorelin compound reference